Chronic Pain & Fibromyalgia Clinical Trials in the UK (2026)

The Chronic Pain Challenge

Chronic pain affects up to 28 million adults in the UK, yet treatment options remain inadequate for many. The opioid crisis has accelerated research into non-opioid alternatives, and the UK is at the forefront of several innovative approaches including novel drug targets, device therapies, and digital interventions.

Non-Opioid Drug Trials

The most active drug trials target new pain mechanisms: selective sodium channel blockers (targeting pain signals without whole-body side effects), anti-NGF antibodies (blocking nerve growth factor involved in pain), novel cannabinoid formulations, and anti-inflammatory biologics for inflammatory pain conditions.

Fibromyalgia-Specific Research

Fibromyalgia trials are investigating the central nervous system mechanisms that amplify pain signals. Active UK studies include novel serotonin-noradrenaline modulators, low-dose naltrexone, digital cognitive behavioural therapy, exercise programmes, and combination approaches targeting both pain and fatigue.

Neuromodulation and Device Trials

Device-based treatments are a rapidly growing area: spinal cord stimulation, peripheral nerve stimulation, transcranial magnetic stimulation, and vagus nerve stimulation are all being tested in UK trials. These approaches offer pain relief without systemic medications and are particularly relevant for patients who cannot tolerate drug treatments.

Digital Pain Management

NHS-linked digital pain management programmes are being evaluated in clinical trials. These include app-based CBT, virtual reality pain distraction, remote physiotherapy, and AI-guided pain self-management. Many such trials offer broad eligibility criteria and can be accessed from home.

Choosing the Right Pain Trial

Consider: your pain type (neuropathic, musculoskeletal, fibromyalgia, mixed), current medications, what you have already tried, and whether you prefer drug, device, or digital approaches. Our chronic pain condition page lists all recruiting UK trials with live data from ClinicalTrials.gov.

Frequently Asked Questions